Fact check
“Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.”
Reasoning
The Wired article explicitly states that Origin Genomics founder Cathy Tie argues that editing human embryos is a moral imperative to address hereditary diseases. The claim matches the wording in the source.
On confidence: Multiple primary source excerpts directly quote Cathy Tie describing gene editing as a “moral imperative” to address hereditary diseases.
Important context
The statement is presented in the context of a commentary by Tie advocating for public funding and regulatory pathways for gene‑edited embryos.
Evidence
Supporting (2)
- Tier 1 — Primary sourceA Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos | WIRED
Kristen V. Brown Science Sep 30, 2026 10:30 AM A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie…
- Tier 1 — Primary sourceA Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos | WIRED
premature. It ended with He in prison. But that hasn’t stopped the push for gene-edited human embryos, with biotech entrepreneur Cathy Tie arguing that doing so isn’t just urgent—it’s a “moral imperative.” Tie is the 30-year-old founder of…
Limitations
The evidence is limited to the Wired article; no additional independent sources were provided to corroborate the statement beyond this publication. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Sep 30, 2026, 6:05 PM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Quotation
Where this claim appeared
A Biotech Founder Makes the Moral Case for Gene-Editing Human EmbryosWired · Kristen V. Brown